High-dose chemotherapy for chronic lymphocytic leukemia: Eligibility, timing, and benefit?

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 9; no. 2; pp. 131 - 132
Main Authors Khouri, I. F., Keating, M. J.
Format Journal Article
LanguageEnglish
Published England Oxford University Press 01.02.1998
Subjects
Antineoplastic Agents - therapeutic use
Combined Modality Therapy
Hematopoietic Stem Cell Transplantation
Humans
Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy
Leukemia, Lymphocytic, Chronic, B-Cell - therapy
Online AccessGet full text

Cover

More Information
Bibliography:ArticleID:9.2.131
istex:981C948AD7FC52E16D40AF1488F748CFED50CE3E
ark:/67375/HXZ-PGKGWLM6-L
SourceType-Other Sources-1
content type line 63
ObjectType-Editorial-2
ObjectType-Commentary-1
ISSN:0923-7534
1569-8041
DOI:10.1023/A:1008259428364